Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	134.79	77.34	32.94
Graham Fair Price	-26.70	17.54	23.92
PEG	185.53	-0.34	0.12
Price/Book	10.81	1.24	1.12
Price/Cash Flow	197.03	13.17	4.43
Prices/Earnings	118.62	16.43	7.51
Price/Sales	-21.23	4.80	6.09
Price/FCF	197.03	13.17	4.43
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-57.34	0.09	0.21
ROA	-49.77	< 0.005	< 0.005
ROE	0.04	0.02	-49.32
ROIC	0.03	0.01	-45.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.01	272.98
Dividends QOQ	0.06	0.03	-58.18
EBIT QOQ	0.54	-0.38	-29.14
EPS QOQ	0.62	-0.48	-23.43
FCF QOQ	1.17	-0.62	-47.25
Revenue QOQ	-0.06	0.44	625.58
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.21	0.22	2.09
Quick Ratio	316.63	0.52	-99.84
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.13	26.91	2.97
Cash	103.91	105.95	1.97
Capex	3.19	0.00	inf
Free Cash Flow	6.60	2.54	-61.59
Revenue	4.80	6.95	44.85
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	34.24	0.06	-99.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.52	-11.93	-116.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating